If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections
No approved vaccine or specific treatment currently available for Bundibugyo strain Ebola disease
Antiviral injection addressing CMV and HSV infections had US market sales of nearly $15 million in the last 12 months
Africa CDC activates continental coordination measures; consultations underway on possible Public Health Emergency declaration
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The initiative aims to encourage women and parents to seek timely medical guidance on cervical cancer prevention and HPV awareness
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
Subscribe To Our Newsletter & Stay Updated
